LEIPZIG, Germany -- May 15, 2015 -- Approximately 20% of children
vertically infected with human immunodeficiency virus (HIV) and
hepatitis C virus (HCV) had already developed liver fibrosis by the end
of adolescence, according to findings presented during a Short Oral
Presentation Session on May 14th at the 33rd Annual Meeting of the
European Society of Paediatric Infectious Diseases (ESPID).
“Rates of sustained viral response were very low in this small
cohort, arousing the need of new therapeutic approaches for this
population that may benefit from new drugs for HCV treatment,” said
Talia Sainz-Costa, MD, Paediatrics, La Paz University Hospital, IdiPAZ
Health Research Institute, Madrid, Spain, who noted the paucity of data
regarding the natural history of children with vertical HIV/HCV
co-infection and their response to anti-HCV treatment.
Labels: Coinfection, pediatric treatment